Search clinical trials for: ChAdOx1 85A

Total 86 results

Universidad del Desarrollo
Pontificia Universidad Catolica de Chile; University of Chile; Ministry of Health...

Active, not recruiting

Reactogenicity, Safety, and Immunogenicity of Covid-19 Vaccine Booster (REFUERZO)

Covid19

Chile
Botswana Harvard AIDS Institute Partnership
AstraZeneca; Botswana Ministry of Health

Completed

Incidence of COVID-19 Following Vaccination in Botswana Against SARS CoV 2

COVID-19

Botswana
University of Oxford
MRC/UVRI and LSHTM Uganda Research Unit

Completed

A Study to Assess the New Candidate Rift Valley Fever Virus Vaccine in Healthy Adults

Rift Valley Fever | RVF

Uganda
University of Oxford

Completed

Research Study to Assess New Chikungunya and Zika Vaccines in Healthy Adults in Mexico.

Chikungunya | Zika

Mexico
University of Oxford

Completed

Safety and Immunogenicity of a Candidate RVFV Vaccine (RVF001)

Rift Valley Fever

United Kingdom
University of Oxford
Imperial College London; KEMRI-Wellcome Trust Collaborative Research Program; University of Nairobi and other collaborators

Active, not recruiting

A Study to Test Three Experimental HIV Vaccines in Healthy Adults. (HIV-CORE 006)

HIV-1-infection

Kenya, Uganda, Zambia
François Spertini
University of Oxford

Completed

ChAdOx1 85A Aerosol Versus Intramuscular Vaccination in Healthy Adults (TB039) (TB039)

Tuberculosis | Mycobacterium Tuberculosis, Protection Against

Switzerland
Assiut University

Active, not recruiting

Safety, Efficacy of Chadox1 Ncov-19 Vaccine: Rapid Systematic Review and Meta Analysis

ChAdOx1 nCoV-19 Vaccine

Egypt
King Abdullah International Medical Research Center
University of Oxford

Completed

A Clinical Trial to Determine the Safety and Immunogenicity of Healthy Candidate MERS-CoV Vaccine (MERS002)

Middle East Respiratory Syndrome Coronavirus

Saudi Arabia
University of Oxford

Active, not recruiting

Investigating a Vaccine Against COVID-19

Coronavirus

United Kingdom
University of Oxford
University of Birmingham

Completed

Safety Study of ChAdOx1 85A Vaccination With and Without MVA85A Boost in Healthy Adults

Tuberculosis

United Kingdom
Vaccitech (UK) Limited

Recruiting

Prime-boost Immunotherapeutic Trial in Men With Biochemical Recurrence After Definitive Local Therapy for Prostate Cancer

Prostate Cancer

United States
Federal University of Espirito Santo
Instituto René Rachou/Fiocruz; Escola Nacional de Saúde Pública Sérgio Arouca... and other collaborators

Recruiting

EFFECTIVENESS, SAFETY AND IMMUNOGENICITY OF THE HALF DOSE OF THE VACCINE ChadOx1 nCoV-19 (AZD1222) for COVID-19

SARS-CoV-2

Brazil
University of Oxford

Completed

A Study of a New Vaccine Against Two Types of Ebola

Ebola

United Kingdom
Vaccitech (UK) Limited

Completed

First in Human Study of ChAdOx1-HBV

Healthy | Hepatitis B

United Kingdom
University of Oxford

Terminated

Safety and Immunogenicity of a Candidate MERS-CoV Vaccine (MERS001)

MERS (Middle East Respiratory Syndrome)

United Kingdom
University of Oxford

Completed

Safety and Immunogenicity of a Candidate CHIKV Vaccine (CHIK001)

Chikungunya Fever

United Kingdom
University of Oxford

Completed

A Study of Intranasal ChAdOx1 nCOV-19

Coronavirus

United Kingdom
CanSino Biologics Inc.

Recruiting

A Study to Evaluate the Safety and Immunogenicity of ChAdOx1-VZV in Healthy Adults Aged 50-65 Years

Herpes Zoster

Canada
University of Oxford

Active, not recruiting

A Study of a Candidate COVID-19 Vaccine (COV001)

Coronavirus

United Kingdom
University of Oxford

Completed

Safety and Immunogenicity of Candidate HIV Vaccines Given Sequentially

Healthy

United Kingdom
University of Oxford

Active, not recruiting

A Study in Tanzania of a New Vaccine Against Two Types of Ebola

Ebola

Tanzania
Federal University of Espirito Santo
Instituto René Rachou/Fiocruz

Recruiting

COVID-19 VACCINE SAFETY AND EFFECTIVENESS

SARS-CoV-2 Infection

Brazil
University of Oxford

Unknown

A Study of a Candidate COVID-19 Vaccine (COV003)

Coronavirus

Brazil
University of Oxford

Completed

Safety and Immunogenicity of a Candidate ZIKV Vaccine (ZIKA001)

Zika

United Kingdom
Korea University Guro Hospital
Ajou University School of Medicine; Korean Center for Disease Control and Prevention and other collaborators

Recruiting

Reactogenicity, Immunogenicity and Inflammatory Response by New COVID-19 Vaccine Platforms

Inflammation | Vaccine Adverse Reaction | Vaccine Immune Response | COVID-19 Vaccination

Korea, Republic of
University of Oxford
Bill and Melinda Gates Foundation; Medical Research Council, South Africa; University... and other collaborators

Unknown

COVID-19 Vaccine (ChAdOx1 nCoV-19) Trial in South African Adults With and Without HIV-infection

Coronavirus

South Africa
National Institute of Allergy and Infectious Diseases...
Gilead Sciences; University of Oxford

Recruiting

Evaluation of Safety, Immunogenicity and Efficacy of a Triple Immune Regimen in Adults Initiated on ART During Acute HIV-1

HIV-1-infection

United States, Brazil
Makerere University
MRC/UVRI and LSHTM Uganda Research Unit; Ministry of Health, Uganda; Epicentre; Makerere University Lung Institute and other collaborators

Not yet recruiting

Solidarity/Tokomeza Ebola Trial (TOKOMEZA)

Sudan Ebola Virus Vaccines
University of Oxford

Completed

A Phase I Study to Determine the Safety and Immunogenicity of the Candidate Influenza Vaccine ChAdOx1-NP+M1

Influenza

United Kingdom
Fundação de Medicina Tropical Dr. Heitor Vieira...
Fundação de Amparo à Pesquisa do Estado do Amazonas (FAPEAM); XP Investimentos and other collaborators

Active, not recruiting

Immune Response of an Interchangeable Booster Vaccine Against COVID-19 Among Individuals With Risk Factors for Severity (COVACManaus2)

Healthy | Comorbidities and Coexisting Conditions

Brazil
Barinthus Biotherapeutics

Completed

Prime-boost Vaccine Study in Women With Low-grade Cervical HPV Lesions

HPV Infection | CIN1

Belgium, United Kingdom, Estonia
University of Oxford

Completed

A Study to Assess Safety and Immunogenicity of Conserved Mosaic HIV-1 Vaccines

HIV

United Kingdom
EuBiologics Co.,Ltd

Recruiting

A Phase III of COVID-19 Vaccine EuCorVac-19 in Healthy Adults Aged 18 Years and Older

COVID-19

Congo, The Democratic Republic of the
EuBiologics Co.,Ltd

Active, not recruiting

A Phase III Study of COVID-19 Vaccine EuCorVac-19 in Healthy Adults

COVID-19

Philippines
Umeå University

Not yet recruiting

Risk of COVID-19 Infection After Vaccination

Covid19 | Vaccination; Infection
Federal University of Espirito Santo
Centro de Pesquisas René Rachou; Secretaria de Estado da Saúde do Espírito...

Not yet recruiting

Effectiveness, Immunogenicity and Safety of the Second Booster Dose of the Vaccine Against COVID-19 in the Elderly (Plus_Booster)

COVID-19 | Vaccine Adverse Reaction | Vaccine-Preventable Diseases

Brazil
University of Oxford

Completed

A Phase I Study of Candidate Influenza Vaccines MVA-NP+M1 and ChAdOx1 NP+M1

Seasonal Influenza

United Kingdom
National Taiwan University Hospital
Taoyuan General Hospital, Ministry of Health and Welfare,Taoyuan,Taiwan

Completed

Efficacy and Safety of Heterologous and Homologous COVID-19 Vaccination

Healthy Adult Volunteers

Taiwan
Universiteit Antwerpen

Completed

Immunogenicity After COVID-19 Vaccines in Adapted Schedules (IMCOVAS)

COVID-19 | Coronavirus Disease 2019

Belgium
Medical University of Vienna

Active, not recruiting

Homologous vs Heterologous Third Vaccination in Kidney Transplant Recipients Kidney Transplant Recipients (BOOST_TX)

COVID-19

Austria
Cancer Research UK
Barinthus Biotherapeutics

Suspended

A Trial of ChAdOx1 and MVA Vaccines Against MAGE-A3 and NY-ESO-1

Esophageal Neoplasms | Non-small Cell Lung Cancer (NSCLC)

United Kingdom
AstraZeneca

Completed

Effectiveness of the Oxford-AstraZeneca COVID-19 Vaccine as a 2nd Booster, the REFORCO-Brazil Study (REFORCO-B)

COVID-19

Brazil
Ministerio de Salud de Ciudad Autónoma de Buenos...

Recruiting

Study to Evaluate the Immunogenicity and Safety of Heterologous SARS-CoV-2 Vaccine Schemes in an Elderly Population

COVID-19 Vaccines

Argentina
Ministerio de Salud de Ciudad Autónoma de Buenos...

Completed

Study to Evaluate the Immunogenicity and Safety of Heterologous SARS-CoV-2 Vaccine Schemes

COVID-19 Vaccines

Argentina
University of Oxford

Completed

A Safety and Efficacy Study of ChAdOx1 LS2 and MVA LS2

Malaria

United Kingdom
Mahidol University
Clinixir Co., Ltd.; Program Management Unit-C (PMU-C), governed by Ministry...

Completed

Third Dose Vaccination With AstraZeneca or Pfizer COVID-19 Vaccine Among Adults Received Sinovac COVID-19 Vaccine

COVID-19 Infection | COVID-19 VACCINE

Thailand
Bangkok Metropolitan Administration Medical College...

Completed

Immunogenicity of the ChAdox1 n CoV-19 Vaccine With 12-dose Vial

Covid19 | Vaccine | Immunogenicity

Thailand
SK Bioscience Co., Ltd.
GlaxoSmithKline; International Vaccine Institute; Coalition for Epidemic Preparedness...

Completed

Immunogenicity and Safety Study of SK SARS-CoV-2 Recombinant Nanoparticle Vaccine (GBP510) Adjuvanted With AS03 (COVID-19)

Covid19

Thailand, Korea, Republic of, New Zealand, Philippines, Ukraine, Vietnam
Vaxxinity, Inc.
Syneos Health; Coalition for Epidemic Preparedness Innovations

Active, not recruiting

Platform Trial to Compare Homologous Boost of Authorized COVID-19 Vaccines and Heterologous Boost With UB-612 Vaccine

COVID-19 Vaccines

Philippines, United States, Panama

Search clinical trials for: ChAdOx1 85A

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Indonesia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations